Skip to main content
Premium Trial:

Request an Annual Quote

Gregg Fergus, Anthony Burgess-Cassler, Dindyal Ramkissoon

Premium
Gregg Fergus has joined NimbleGen’s board of directors, the company said this week.
 
Fergus formerly was senior vice president of sales and global operations at Affymetrix and was chief commercial officer at Cellular Dynamics and Stem Cell Products.
 
Fergus also has consulted for Caden Biosciences and was an executive in residence at Baird Venture Partners.
 

 
Anthony Burgess-Cassler has been named senior scientist at QuantRx's Corporate Research Center in Portland, Ore., the firm said this week.
 
Burgess-Cassler joined QuantRx from Calypte Biomedical. He holds a BS in chemistry from ValparaisoUniversity in Indiana and a PhD in biochemistry from the University of Illinois-Urbana.
 

 
Dindyal Ramkissoon has been appointed vice president of sales and marketing of CombiMatrix Molecular Diagnostics, CMDX's parent CombiMatrix said this week.
 
Ramkissoon will be responsible for leading CMDX’s marketing initiatives for its molecular diagnostics business and for assembling CMDX’s national sales organization.
 
He previously held similar positions at Applied Spectral-Imaging, Cyberonics, and Applied Imaging. Ramkissoob holds a BS in biology from Winona State University in Minnesota.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.